| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | MED15 SUPT20HL1 KMT2C ARID1B KMT2D SUPT20H HDAC5 TOX3 MAML1 HIPK2 MAML2 HCFC1 MRTFA RBCK1 | 2.42e-11 | 562 | 47 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.76e-09 | 303 | 47 | 10 | GO:0003713 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | MED15 SUPT20HL1 KMT2C ARID1B KMT2D SUPT20H SGTB HDAC5 TOX3 MAML1 HIPK2 GIGYF2 MAML2 HCFC1 MRTFA RBCK1 | 3.76e-08 | 1356 | 47 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MED15 SUPT20HL1 KMT2C ARID1B KMT2D SUPT20H HDAC5 TOX3 MAML1 HIPK2 MAML2 HCFC1 MRTFA RBCK1 | 2.58e-07 | 1160 | 47 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX6 SOX5 GTF2A1 CPHXL USF3 HDAC5 SATB1 ZFHX4 FOXP2 TP63 FOXP1 ZFHX3 SOX13 HCFC1 TFCP2 | 6.77e-07 | 1459 | 47 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | chromatin binding | PHC3 ARID1B HDAC5 SATB1 ATXN1 TP63 TOX3 ANKRD17 FOXP1 CHD1 HCFC1 | 8.54e-07 | 739 | 47 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX6 SOX5 CPHXL KMT2D USF3 HDAC5 SATB1 ZFHX4 FOXP2 TP63 FOXP1 ZFHX3 SOX13 TFCP2 | 2.73e-06 | 1412 | 47 | 14 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX6 SOX5 CPHXL HDAC5 SATB1 ZFHX4 FOXP2 TP63 FOXP1 ZFHX3 SOX13 HCFC1 TFCP2 | 3.84e-06 | 1244 | 47 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX6 SOX5 CPHXL HDAC5 SATB1 ZFHX4 FOXP2 TP63 FOXP1 ZFHX3 SOX13 HCFC1 TFCP2 | 4.86e-06 | 1271 | 47 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 9.22e-06 | 320 | 47 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.04e-05 | 326 | 47 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | transcription factor binding | 5.53e-05 | 753 | 47 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.50e-04 | 8 | 47 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.41e-04 | 10 | 47 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.27e-04 | 140 | 47 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.94e-04 | 582 | 47 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.00e-03 | 20 | 47 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.73e-03 | 33 | 47 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.89e-03 | 417 | 47 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 4.82e-03 | 44 | 47 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 7.44e-03 | 55 | 47 | 2 | GO:0001046 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX6 MED15 SUPT20HL1 KMT2C GTF2A1 KMT2D USF3 SUPT20H HDAC5 ATXN1 TP63 TOX3 PAXIP1 MAML1 HIPK2 FOXP1 ZFHX3 MAML2 HCFC1 TFCP2 MRTFA RBCK1 | 4.18e-14 | 1390 | 47 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MED15 KMT2C GTF2A1 ARID1B KMT2D HDAC5 SATB1 TP63 PAXIP1 HIPK2 CHD1 HCFC1 | 1.69e-06 | 999 | 47 | 12 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | 5.23e-06 | 741 | 47 | 10 | GO:0006338 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX6 SOX5 PHC3 HDAC5 SATB1 FOXP2 ATXN1 TP63 HIPK2 FOXP1 ZFHX3 SOX13 HCFC1 | 9.71e-06 | 1399 | 47 | 13 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX6 SOX5 PHC3 HDAC5 SATB1 FOXP2 ATXN1 TP63 HIPK2 FOXP1 ZFHX3 SOX13 HCFC1 | 1.08e-05 | 1413 | 47 | 13 | GO:1902679 |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 1.52e-05 | 3 | 47 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX6 HDAC5 SATB1 FOXP2 ATXN1 TP63 HIPK2 FOXP1 ZFHX3 SOX13 HCFC1 | 1.86e-05 | 1053 | 47 | 11 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 1.93e-05 | 246 | 47 | 6 | GO:1902806 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.73e-05 | 896 | 47 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell differentiation | 3.04e-05 | 4 | 47 | 2 | GO:2000741 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell differentiation | 3.81e-05 | 83 | 47 | 4 | GO:0051148 | |
| GeneOntologyBiologicalProcess | spinal cord oligodendrocyte cell differentiation | 5.06e-05 | 5 | 47 | 2 | GO:0021529 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 6.53e-05 | 306 | 47 | 6 | GO:0044843 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 8.77e-05 | 199 | 47 | 5 | GO:0051147 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 1.06e-04 | 7 | 47 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | muscle structure development | 1.17e-04 | 858 | 47 | 9 | GO:0061061 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 1.56e-04 | 516 | 47 | 7 | GO:1901987 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell differentiation | 1.76e-04 | 123 | 47 | 4 | GO:0051153 | |
| GeneOntologyBiologicalProcess | negative regulation of striated muscle cell differentiation | 2.14e-04 | 51 | 47 | 3 | GO:0051154 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal stem cell differentiation | 2.76e-04 | 11 | 47 | 2 | GO:2000739 | |
| GeneOntologyBiologicalProcess | embryo development | SOX6 SOX5 SUPT20HL1 KMT2D SUPT20H FOXP2 TP63 HIPK2 FOXP1 TNRC6C HCFC1 | 3.05e-04 | 1437 | 47 | 11 | GO:0009790 |
| GeneOntologyBiologicalProcess | lung development | 3.56e-04 | 269 | 47 | 5 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 3.81e-04 | 273 | 47 | 5 | GO:0030323 | |
| GeneOntologyBiologicalProcess | cell differentiation in spinal cord | 4.00e-04 | 63 | 47 | 3 | GO:0021515 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell differentiation | 4.54e-04 | 14 | 47 | 2 | GO:0072497 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 5.07e-04 | 627 | 47 | 7 | GO:0044770 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 5.45e-04 | 70 | 47 | 3 | GO:0060261 | |
| GeneOntologyBiologicalProcess | respiratory system development | 6.31e-04 | 305 | 47 | 5 | GO:0060541 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 6.67e-04 | 75 | 47 | 3 | GO:0048286 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 7.21e-04 | 77 | 47 | 3 | GO:2000144 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle G1/S phase transition | 8.06e-04 | 80 | 47 | 3 | GO:1902808 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 8.35e-04 | 81 | 47 | 3 | GO:0060260 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 8.44e-04 | 186 | 47 | 4 | GO:0006367 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.03e-03 | 87 | 47 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.07e-03 | 343 | 47 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | striatum development | 1.14e-03 | 22 | 47 | 2 | GO:0021756 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.15e-03 | 202 | 47 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 1.17e-03 | 91 | 47 | 3 | GO:2000142 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 1.24e-03 | 531 | 47 | 6 | GO:0042692 | |
| GeneOntologyBiologicalProcess | cartilage condensation | 1.25e-03 | 23 | 47 | 2 | GO:0001502 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.32e-03 | 210 | 47 | 4 | GO:0007219 | |
| GeneOntologyBiologicalProcess | DNA damage response | 1.33e-03 | 959 | 47 | 8 | GO:0006974 | |
| GeneOntologyBiologicalProcess | central nervous system development | 1.34e-03 | 1197 | 47 | 9 | GO:0007417 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.36e-03 | 24 | 47 | 2 | GO:0071625 | |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte differentiation | 1.36e-03 | 24 | 47 | 2 | GO:0032332 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 1.39e-03 | 213 | 47 | 4 | GO:2000045 | |
| GeneOntologyCellularComponent | chromatin | SOX6 SOX5 SUPT20HL1 ARID1B SUPT20H HDAC5 SATB1 ZFHX4 FOXP2 TP63 ANKRD17 FOXP1 ZFHX3 CHD1 SOX13 HCFC1 TFCP2 | 9.16e-09 | 1480 | 47 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.31e-06 | 12 | 47 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.43e-05 | 75 | 47 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | transcription regulator complex | 4.91e-05 | 596 | 47 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.01e-04 | 108 | 47 | 4 | GO:0034708 | |
| GeneOntologyCellularComponent | transferase complex | SUPT20HL1 KMT2C GTF2A1 PHC3 KMT2D SUPT20H PAXIP1 HCFC1 RBCK1 | 2.53e-04 | 963 | 47 | 9 | GO:1990234 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 3.35e-04 | 269 | 47 | 5 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 4.51e-04 | 287 | 47 | 5 | GO:0035770 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MED15 KMT2C GTF2A1 PHC3 ARID1B KMT2D HDAC5 PAXIP1 HIPK2 HCFC1 | 8.18e-04 | 1377 | 47 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.24e-03 | 94 | 47 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | SAGA complex | 1.44e-03 | 25 | 47 | 2 | GO:0000124 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.65e-03 | 104 | 47 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.89e-03 | 109 | 47 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | SAGA-type complex | 3.48e-03 | 39 | 47 | 2 | GO:0070461 | |
| GeneOntologyCellularComponent | nuclear body | 3.81e-03 | 903 | 47 | 7 | GO:0016604 | |
| GeneOntologyCellularComponent | nuclear matrix | 3.84e-03 | 140 | 47 | 3 | GO:0016363 | |
| GeneOntologyCellularComponent | nuclear periphery | 6.70e-03 | 171 | 47 | 3 | GO:0034399 | |
| HumanPheno | Prominent fingertip pads | 2.23e-06 | 46 | 25 | 5 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 2.77e-06 | 48 | 25 | 5 | HP:0011298 | |
| HumanPheno | Expressive language delay | 6.02e-06 | 56 | 25 | 5 | HP:0002474 | |
| HumanPheno | Language delay | 6.02e-06 | 56 | 25 | 5 | HP:0002336 | |
| HumanPheno | Thick eyebrow | 6.12e-06 | 154 | 25 | 7 | HP:0000574 | |
| HumanPheno | Abnormality of the palpebral fissures | SOX6 SOX5 KMT2C ARID1B KMT2D SATB1 FOXP2 TP63 PCLO SASS6 ANKRD17 FOXP1 CHD1 MN1 | 1.29e-05 | 880 | 25 | 14 | HP:0008050 |
| HumanPheno | Allergy | 4.04e-05 | 41 | 25 | 4 | HP:0012393 | |
| HumanPheno | Abnormal midface morphology | SOX5 KMT2C ARID1B KMT2D SATB1 FOXP2 TP63 PCLO ANKRD17 FOXP1 CHD1 MN1 | 4.09e-05 | 704 | 25 | 12 | HP:0000309 |
| HumanPheno | Brachycephaly | 1.53e-04 | 253 | 25 | 7 | HP:0000248 | |
| HumanPheno | Abnormality of calvarial morphology | SOX6 SOX5 KMT2C ARID1B KMT2D SATB1 FOXP2 TP63 PCLO ANKRD17 CHD1 SIK3 MN1 HCFC1 | 2.48e-04 | 1134 | 25 | 14 | HP:0002648 |
| HumanPheno | Functional abnormality of the bladder | 2.59e-04 | 590 | 25 | 10 | HP:0000009 | |
| MousePheno | perinatal lethality | SOX6 SOX5 KMT2C GTF2A1 ARID1B ZFHX4 FOXP2 TP63 GIGYF2 TNRC6C SIK3 SUCLA2 MN1 | 2.16e-05 | 1130 | 43 | 13 | MP:0002081 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | SOX6 SOX5 KMT2C ARID1B SATB1 ZFHX4 FOXP2 TP63 MAML1 FOXP1 TNRC6C SUCLA2 MN1 | 7.32e-05 | 1269 | 43 | 13 | MP:0011111 |
| MousePheno | abnormal maxilla morphology | 7.60e-05 | 144 | 43 | 5 | MP:0000455 | |
| MousePheno | abnormal exploration in a new environment | 1.26e-04 | 647 | 43 | 9 | MP:0013189 | |
| MousePheno | delayed eyelid opening | 1.39e-04 | 33 | 43 | 3 | MP:0001290 | |
| MousePheno | decreased exploration in new environment | 1.40e-04 | 510 | 43 | 8 | MP:0001417 | |
| MousePheno | abnormal response to new environment | 1.99e-04 | 687 | 43 | 9 | MP:0001413 | |
| MousePheno | abnormal left-right axis symmetry of the somites | 2.56e-04 | 8 | 43 | 2 | MP:0005224 | |
| MousePheno | abnormal breathing pattern | 3.06e-04 | 303 | 43 | 6 | MP:0001951 | |
| MousePheno | incomplete somite formation | 3.29e-04 | 44 | 43 | 3 | MP:0001689 | |
| MousePheno | respiratory distress | 3.86e-04 | 204 | 43 | 5 | MP:0001954 | |
| MousePheno | abnormal viscerocranium morphology | 3.89e-04 | 593 | 43 | 8 | MP:0005274 | |
| MousePheno | abnormal gastrulation movements | 4.09e-04 | 10 | 43 | 2 | MP:0002174 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | SOX6 GTF2A1 FOXP2 TP63 MAML1 GIGYF2 FOXP1 ZFHX3 SIK3 MN1 HCFC1 | 4.50e-04 | 1124 | 43 | 11 | MP:0011112 |
| MousePheno | abnormal palatal shelf morphology | 5.08e-04 | 121 | 43 | 4 | MP:0031460 | |
| MousePheno | abnormal response to novelty | 5.42e-04 | 787 | 43 | 9 | MP:0003107 | |
| MousePheno | abnormal secondary palate development | 5.57e-04 | 124 | 43 | 4 | MP:0009655 | |
| MousePheno | caudal body truncation | 6.03e-04 | 54 | 43 | 3 | MP:0004073 | |
| MousePheno | neonatal lethality | 6.05e-04 | 799 | 43 | 9 | MP:0002058 | |
| MousePheno | abnormal palate development | 6.46e-04 | 129 | 43 | 4 | MP:0009653 | |
| MousePheno | abnormal cranium morphology | 6.86e-04 | 813 | 43 | 9 | MP:0000438 | |
| MousePheno | abnormal rostral-caudal axis patterning | 7.05e-04 | 132 | 43 | 4 | MP:0005221 | |
| MousePheno | abnormal visceral yolk sac morphology | 7.50e-04 | 236 | 43 | 5 | MP:0001718 | |
| MousePheno | abnormal craniofacial bone morphology | 7.76e-04 | 827 | 43 | 9 | MP:0002116 | |
| MousePheno | perinatal lethality, incomplete penetrance | 7.84e-04 | 503 | 43 | 7 | MP:0011090 | |
| MousePheno | abnormal timing of postnatal eyelid opening | 8.62e-04 | 61 | 43 | 3 | MP:0004874 | |
| Domain | HMG_box | 2.92e-09 | 53 | 45 | 6 | PF00505 | |
| Domain | HMG | 3.28e-09 | 54 | 45 | 6 | SM00398 | |
| Domain | HMG_box_dom | 1.03e-08 | 65 | 45 | 6 | IPR009071 | |
| Domain | - | 2.05e-07 | 55 | 45 | 5 | 1.10.30.10 | |
| Domain | HMG_BOX_2 | 8.51e-06 | 54 | 45 | 4 | PS50118 | |
| Domain | Neuroggenic_mastermind-like_N | 1.70e-05 | 3 | 45 | 2 | IPR019082 | |
| Domain | MamL-1 | 1.70e-05 | 3 | 45 | 2 | SM01275 | |
| Domain | MamL-1 | 1.70e-05 | 3 | 45 | 2 | PF09596 | |
| Domain | FOXP-CC | 3.40e-05 | 4 | 45 | 2 | PF16159 | |
| Domain | FOXP-CC | 3.40e-05 | 4 | 45 | 2 | IPR032354 | |
| Domain | FYrich_C | 5.65e-05 | 5 | 45 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.65e-05 | 5 | 45 | 2 | IPR003888 | |
| Domain | FYRC | 5.65e-05 | 5 | 45 | 2 | SM00542 | |
| Domain | FYRN | 5.65e-05 | 5 | 45 | 2 | SM00541 | |
| Domain | FYRN | 5.65e-05 | 5 | 45 | 2 | PF05964 | |
| Domain | FYRC | 5.65e-05 | 5 | 45 | 2 | PF05965 | |
| Domain | FYRC | 5.65e-05 | 5 | 45 | 2 | PS51543 | |
| Domain | FYRN | 5.65e-05 | 5 | 45 | 2 | PS51542 | |
| Domain | Post-SET_dom | 6.67e-04 | 16 | 45 | 2 | IPR003616 | |
| Domain | PostSET | 6.67e-04 | 16 | 45 | 2 | SM00508 | |
| Domain | POST_SET | 6.67e-04 | 16 | 45 | 2 | PS50868 | |
| Domain | EPHD | 1.27e-03 | 22 | 45 | 2 | PS51805 | |
| Domain | tRNA-bd_arm | 1.51e-03 | 24 | 45 | 2 | IPR010978 | |
| Domain | ZnF_U1 | 2.21e-03 | 29 | 45 | 2 | SM00451 | |
| Domain | Znf_U1 | 2.21e-03 | 29 | 45 | 2 | IPR003604 | |
| Domain | SAM/pointed | 2.81e-03 | 117 | 45 | 3 | IPR013761 | |
| Domain | SET | 4.38e-03 | 41 | 45 | 2 | PF00856 | |
| Domain | UBA | 5.04e-03 | 44 | 45 | 2 | IPR015940 | |
| Domain | Znf_FYVE_PHD | 5.32e-03 | 147 | 45 | 3 | IPR011011 | |
| Domain | TF_fork_head_CS_2 | 5.49e-03 | 46 | 45 | 2 | IPR030456 | |
| Domain | SET | 5.49e-03 | 46 | 45 | 2 | SM00317 | |
| Domain | UBA | 5.73e-03 | 47 | 45 | 2 | PS50030 | |
| Domain | TF_fork_head_CS_1 | 5.73e-03 | 47 | 45 | 2 | IPR018122 | |
| Domain | FORK_HEAD_3 | 6.21e-03 | 49 | 45 | 2 | PS50039 | |
| Domain | FH | 6.21e-03 | 49 | 45 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 6.21e-03 | 49 | 45 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 6.21e-03 | 49 | 45 | 2 | PS00658 | |
| Domain | Forkhead | 6.21e-03 | 49 | 45 | 2 | PF00250 | |
| Domain | Fork_head_dom | 6.21e-03 | 49 | 45 | 2 | IPR001766 | |
| Domain | SET_dom | 6.46e-03 | 50 | 45 | 2 | IPR001214 | |
| Domain | SET | 6.46e-03 | 50 | 45 | 2 | PS50280 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.43e-07 | 23 | 37 | 4 | MM14954 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 7.86e-07 | 28 | 37 | 4 | M6177 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.97e-06 | 10 | 37 | 3 | MM15535 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.60e-06 | 12 | 37 | 3 | M27159 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 4.19e-06 | 42 | 37 | 4 | M48018 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MED15 KMT2C GTF2A1 PHC3 ARID1B KMT2D HDAC5 TP63 MAMLD1 MAML1 HIPK2 ZFHX3 MAML2 TNRC6C | 5.16e-06 | 1387 | 37 | 14 | M734 |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.94e-06 | 14 | 37 | 3 | M27808 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | GTF2A1 PHC3 KMT2D HDAC5 TP63 MAMLD1 PAXIP1 MAML1 HIPK2 ZFHX3 MAML2 HCFC1 | 6.69e-06 | 1022 | 37 | 12 | MM15436 |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.19e-06 | 48 | 37 | 4 | M611 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 9.10e-06 | 16 | 37 | 3 | M27121 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.32e-05 | 18 | 37 | 3 | MM14775 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.54e-05 | 58 | 37 | 4 | M29616 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.84e-05 | 20 | 37 | 3 | M27881 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.18e-05 | 237 | 37 | 6 | M27786 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.68e-05 | 25 | 37 | 3 | M27880 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.05e-05 | 74 | 37 | 4 | M616 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 4.50e-05 | 76 | 37 | 4 | MM15520 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 5.80e-05 | 29 | 37 | 3 | M48076 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 8.60e-05 | 33 | 37 | 3 | M604 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.12e-04 | 96 | 37 | 4 | M27784 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.22e-04 | 37 | 37 | 3 | M27797 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.26e-04 | 768 | 37 | 9 | MM14851 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.32e-04 | 38 | 37 | 3 | MM17073 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.43e-04 | 39 | 37 | 3 | MM14604 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.54e-04 | 40 | 37 | 3 | MM15000 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.78e-04 | 42 | 37 | 3 | M17541 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.78e-04 | 42 | 37 | 3 | M27272 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.05e-04 | 44 | 37 | 3 | M27295 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.57e-04 | 119 | 37 | 4 | M607 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.82e-04 | 49 | 37 | 3 | M618 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 4.29e-04 | 246 | 37 | 5 | M10189 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 4.35e-04 | 12 | 37 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 4.35e-04 | 12 | 37 | 2 | M47533 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 4.97e-04 | 254 | 37 | 5 | M27131 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 5.13e-04 | 13 | 37 | 2 | M47534 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.78e-04 | 272 | 37 | 5 | M29619 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 7.74e-04 | 69 | 37 | 3 | M46439 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MED15 KMT2C ARID1B KMT2D TP63 MAMLD1 PAXIP1 MAML1 FOXP1 MAML2 TNRC6C | 8.07e-04 | 1432 | 37 | 11 | M509 |
| Pathway | REACTOME_SUMOYLATION | 9.67e-04 | 169 | 37 | 4 | MM14919 | |
| Pathway | WP_16P112_PROXIMAL_DELETION_SYNDROME | 1.03e-03 | 76 | 37 | 3 | M40057 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.28e-03 | 82 | 37 | 3 | M594 | |
| Pathway | REACTOME_SUMOYLATION | 1.46e-03 | 189 | 37 | 4 | M27214 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.01e-03 | 96 | 37 | 3 | M27792 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 2.09e-03 | 26 | 37 | 2 | M2499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 2.09e-03 | 26 | 37 | 2 | M47923 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.26e-03 | 27 | 37 | 2 | M39545 | |
| Pathway | WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS | 2.78e-03 | 30 | 37 | 2 | M39775 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.16e-03 | 32 | 37 | 2 | M27900 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.16e-03 | 32 | 37 | 2 | MM14975 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.57e-03 | 34 | 37 | 2 | MM15531 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 3.96e-03 | 122 | 37 | 3 | M29689 | |
| Pathway | REACTOME_GASTRULATION | 4.64e-03 | 129 | 37 | 3 | M46433 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 5.37e-03 | 136 | 37 | 3 | MM14848 | |
| Pathway | REACTOME_PTEN_REGULATION | 5.71e-03 | 139 | 37 | 3 | M27646 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 6.17e-03 | 143 | 37 | 3 | M39591 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 6.73e-03 | 47 | 37 | 2 | M7946 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 6.91e-03 | 464 | 37 | 5 | M27547 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 6.91e-03 | 149 | 37 | 3 | M27888 | |
| Pathway | PID_HES_HEY_PATHWAY | 7.01e-03 | 48 | 37 | 2 | M288 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 7.43e-03 | 153 | 37 | 3 | MM15522 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 8.12e-03 | 158 | 37 | 3 | MM14791 | |
| Pubmed | SOX6 MED15 SOX5 KMT2C PHC3 ARID1B KMT2D SUPT20H HDAC5 SATB1 ZFHX4 DCP1B FOXP2 ATXN1 PAXIP1 MAML1 HIPK2 ANKRD17 GIGYF2 HELZ FOXP1 ZFHX3 TNRC6C SOX13 HCFC1 TFCP2 | 1.70e-23 | 1429 | 49 | 26 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | MED15 SOX5 KMT2C ARID1B KMT2D HDAC5 SATB1 ZFHX4 FOXP2 ATXN1 PAXIP1 MAML1 FOXP1 ZFHX3 SOX13 | 9.83e-19 | 351 | 49 | 15 | 38297188 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | MED15 SOX5 KMT2C PHC3 ARID1B KMT2D SUPT20H ZFHX4 PCLO PAXIP1 MAML1 FOXP1 TFCP2 | 8.59e-15 | 398 | 49 | 13 | 35016035 |
| Pubmed | 5.64e-13 | 23 | 49 | 6 | 9225980 | ||
| Pubmed | 2.09e-12 | 28 | 49 | 6 | 29365100 | ||
| Pubmed | SOX6 SOX5 GTF2A1 CPHXL SATB1 FOXP2 ATXN1 TOX3 FOXP1 ZFHX3 SOX13 TFCP2 MRTFA | 6.34e-11 | 808 | 49 | 13 | 20412781 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX6 SOX5 KMT2D USF3 SATB1 ZFHX4 FOXP2 TP63 TOX3 FOXP1 ZFHX3 SOX13 TFCP2 | 2.65e-10 | 908 | 49 | 13 | 19274049 |
| Pubmed | PHC3 KMT2D HDAC5 SATB1 ZFHX4 ANKRD17 GIGYF2 FOXP1 ZFHX3 MRTFA | 3.06e-10 | 418 | 49 | 10 | 34709266 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | MED15 KMT2C ARID1B KMT2D DCP1B MAMLD1 MAML1 ANKRD17 HELZ SUCLA2 | 7.23e-10 | 457 | 49 | 10 | 32344865 |
| Pubmed | KMT2C GTF2A1 USF3 SUPT20H ATXN1 HIPK2 ANKRD17 GIGYF2 HELZ SIK3 | 1.31e-09 | 486 | 49 | 10 | 20936779 | |
| Pubmed | 3.84e-09 | 268 | 49 | 8 | 33640491 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 2.50e-08 | 22 | 49 | 4 | 26886794 | |
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 16627753 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 26744420 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 1.06e-07 | 31 | 49 | 4 | 20516061 | |
| Pubmed | The transcription factor Sox5 modulates Sox10 function during melanocyte development. | 1.46e-07 | 8 | 49 | 3 | 18703590 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | HDAC5 DCP1B AAK1 PAXIP1 MAML1 GIGYF2 PALMD TNRC6C SOX13 TFCP2 MRTFA | 1.64e-07 | 1038 | 49 | 11 | 26673895 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KMT2D HDAC5 SATB1 ZFHX4 FOXP2 MAML1 ANKRD17 FOXP1 HCFC1 TFCP2 | 2.70e-07 | 857 | 49 | 10 | 25609649 |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 3.09e-07 | 318 | 49 | 7 | 16919269 | |
| Pubmed | 3.13e-07 | 10 | 49 | 3 | 10037800 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 3.33e-07 | 877 | 49 | 10 | 20211142 | |
| Pubmed | 5.73e-07 | 12 | 49 | 3 | 26525805 | ||
| Pubmed | 5.73e-07 | 12 | 49 | 3 | 27563068 | ||
| Pubmed | 5.73e-07 | 12 | 49 | 3 | 34234180 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.67e-07 | 220 | 49 | 6 | 35785414 | |
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 7.44e-07 | 13 | 49 | 3 | 17761849 | |
| Pubmed | 7.60e-07 | 225 | 49 | 6 | 12168954 | ||
| Pubmed | 7.63e-07 | 50 | 49 | 4 | 37974198 | ||
| Pubmed | 9.46e-07 | 14 | 49 | 3 | 8921394 | ||
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 1.18e-06 | 15 | 49 | 3 | 30871468 | |
| Pubmed | 1.18e-06 | 15 | 49 | 3 | 17925232 | ||
| Pubmed | 1.45e-06 | 16 | 49 | 3 | 24368734 | ||
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 26180087 | ||
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 1.76e-06 | 17 | 49 | 3 | 27241892 | |
| Pubmed | 1.88e-06 | 263 | 49 | 6 | 20932939 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28483418 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 30031127 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 1.94e-06 | 2 | 49 | 2 | 30104377 | |
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 1.94e-06 | 2 | 49 | 2 | 34156443 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 9524265 | ||
| Pubmed | KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis. | 1.94e-06 | 2 | 49 | 2 | 29440247 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 36898841 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 31924266 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 27280393 | ||
| Pubmed | Generation of mice harboring a Sox5 conditional null allele. | 1.94e-06 | 2 | 49 | 2 | 18543318 | |
| Pubmed | Variants in HCFC1 and MN1 genes causing intellectual disability in two Pakistani families. | 1.94e-06 | 2 | 49 | 2 | 38956580 | |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 1.94e-06 | 2 | 49 | 2 | 10873665 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 36869380 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28967912 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24893771 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24893616 | ||
| Pubmed | HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. | 1.94e-06 | 2 | 49 | 2 | 21602882 | |
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 1.94e-06 | 2 | 49 | 2 | 15056695 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25853299 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 27224915 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25346535 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11358962 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28741757 | ||
| Pubmed | Compensation between FOXP transcription factors maintains proper striatal function. | 1.94e-06 | 2 | 49 | 2 | 38761373 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11585348 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 36601880 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26647308 | ||
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 2.11e-06 | 18 | 49 | 3 | 17500065 | |
| Pubmed | 2.11e-06 | 18 | 49 | 3 | 26864488 | ||
| Pubmed | 2.21e-06 | 65 | 49 | 4 | 26655900 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 2.81e-06 | 69 | 49 | 4 | 28481362 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.85e-06 | 444 | 49 | 7 | 34795231 | |
| Pubmed | ARID1B SUPT20H ZFHX4 FOXP2 ATXN1 ANKRD17 HELZ FOXP1 ZFHX3 SIK3 | 2.93e-06 | 1116 | 49 | 10 | 31753913 | |
| Pubmed | 2.95e-06 | 20 | 49 | 3 | 11404013 | ||
| Pubmed | 2.95e-06 | 20 | 49 | 3 | 35177643 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 2.95e-06 | 20 | 49 | 3 | 29785026 | |
| Pubmed | 2.95e-06 | 20 | 49 | 3 | 19047629 | ||
| Pubmed | 2.95e-06 | 20 | 49 | 3 | 33431871 | ||
| Pubmed | 3.43e-06 | 21 | 49 | 3 | 29659575 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 3.86e-06 | 167 | 49 | 5 | 20362541 | |
| Pubmed | 5.08e-06 | 80 | 49 | 4 | 35803934 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.48e-06 | 934 | 49 | 9 | 33916271 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KMT2C USF3 ATXN1 TOX3 AAK1 HIPK2 ANKRD17 FOXP1 ZFHX3 TNRC6C SUCLA2 | 5.54e-06 | 1489 | 49 | 11 | 28611215 |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 12386158 | ||
| Pubmed | SoxD genes are required for adult neural stem cell activation. | 5.83e-06 | 3 | 49 | 2 | 35108528 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 28653891 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 14516685 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 26045173 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 26150426 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 5.83e-06 | 3 | 49 | 2 | 19907493 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23932714 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 28507505 | ||
| Pubmed | Generation of mice harboring a Sox6 conditional null allele. | 5.83e-06 | 3 | 49 | 2 | 16652367 | |
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 5.83e-06 | 3 | 49 | 2 | 22183980 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15529345 | ||
| Pubmed | Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. | 5.83e-06 | 3 | 49 | 2 | 12687690 | |
| Pubmed | SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. | 5.83e-06 | 3 | 49 | 2 | 21728837 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24220028 | ||
| Pubmed | SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells. | 5.83e-06 | 3 | 49 | 2 | 28687615 | |
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 5.83e-06 | 3 | 49 | 2 | 25027557 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21401405 | ||
| Pubmed | Identification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1. | 5.83e-06 | 3 | 49 | 2 | 22916034 | |
| Pubmed | Foxp1 expression is essential for sex-specific murine neonatal ultrasonic vocalization. | 5.83e-06 | 3 | 49 | 2 | 28204507 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21683083 | ||
| Pubmed | 5.89e-06 | 83 | 49 | 4 | 28794006 | ||
| Interaction | FEV interactions | SOX5 KMT2C PHC3 ARID1B KMT2D SUPT20H SATB1 ZFHX4 FOXP2 ATXN1 PAXIP1 MAML1 FOXP1 ZFHX3 SOX13 | 3.74e-19 | 203 | 47 | 15 | int:FEV |
| Interaction | GSC interactions | SOX5 KMT2C ARID1B KMT2D ZFHX4 FOXP2 ATXN1 PAXIP1 FOXP1 ZFHX3 SOX13 | 7.74e-17 | 87 | 47 | 11 | int:GSC |
| Interaction | EGR2 interactions | SOX5 KMT2C ARID1B KMT2D HDAC5 ZFHX4 FOXP2 ATXN1 PAXIP1 MAML1 FOXP1 ZFHX3 HCFC1 | 8.15e-17 | 171 | 47 | 13 | int:EGR2 |
| Interaction | HNF1B interactions | SOX6 SOX5 KMT2C ARID1B KMT2D SATB1 ZFHX4 ATXN1 PAXIP1 MAML1 FOXP1 ZFHX3 SOX13 | 3.27e-16 | 190 | 47 | 13 | int:HNF1B |
| Interaction | CRX interactions | MED15 SOX5 KMT2C ARID1B KMT2D MYO15B ZFHX4 FOXP2 ATXN1 PAXIP1 MAML1 FOXP1 ZFHX3 | 1.43e-14 | 254 | 47 | 13 | int:CRX |
| Interaction | TBR1 interactions | SOX5 KMT2C ARID1B KMT2D ZFHX4 FOXP2 ATXN1 PAXIP1 MAML1 ZFHX3 | 8.91e-14 | 113 | 47 | 10 | int:TBR1 |
| Interaction | PAX7 interactions | KMT2C ARID1B KMT2D SATB1 ZFHX4 ATXN1 PAXIP1 MAML1 FOXP1 ZFHX3 | 2.30e-13 | 124 | 47 | 10 | int:PAX7 |
| Interaction | PAX9 interactions | KMT2C ARID1B KMT2D SATB1 ZFHX4 ATXN1 PAXIP1 MAML1 FOXP1 ZFHX3 | 3.71e-13 | 130 | 47 | 10 | int:PAX9 |
| Interaction | NFIB interactions | 9.07e-13 | 142 | 47 | 10 | int:NFIB | |
| Interaction | CTBP1 interactions | SOX6 MED15 PHC3 HDAC5 SATB1 FOXP2 ATXN1 PCLO MAML1 HIPK2 HELZ FOXP1 MAML2 | 5.63e-12 | 406 | 47 | 13 | int:CTBP1 |
| Interaction | TBXT interactions | 5.74e-12 | 116 | 47 | 9 | int:TBXT | |
| Interaction | TEAD1 interactions | KMT2C ARID1B KMT2D SATB1 ZFHX4 ATXN1 TP63 PAXIP1 FOXP1 ZFHX3 | 7.82e-12 | 176 | 47 | 10 | int:TEAD1 |
| Interaction | LHX2 interactions | KMT2C ARID1B KMT2D SATB1 ZFHX4 ATXN1 PAXIP1 FOXP1 ZFHX3 MRTFA | 1.15e-11 | 183 | 47 | 10 | int:LHX2 |
| Interaction | SOX7 interactions | 1.46e-11 | 82 | 47 | 8 | int:SOX7 | |
| Interaction | GATA2 interactions | KMT2C ARID1B KMT2D HDAC5 SATB1 ZFHX4 ATXN1 PAXIP1 FOXP1 ZFHX3 | 2.65e-11 | 199 | 47 | 10 | int:GATA2 |
| Interaction | ERG interactions | SOX6 KMT2C ARID1B KMT2D ZFHX4 ATXN1 PAXIP1 MAML1 HIPK2 FOXP1 | 8.14e-11 | 223 | 47 | 10 | int:ERG |
| Interaction | SOX6 interactions | 8.88e-11 | 157 | 47 | 9 | int:SOX6 | |
| Interaction | NFIX interactions | 9.70e-11 | 227 | 47 | 10 | int:NFIX | |
| Interaction | SOX5 interactions | 1.18e-10 | 162 | 47 | 9 | int:SOX5 | |
| Interaction | PAX8 interactions | 1.73e-10 | 111 | 47 | 8 | int:PAX8 | |
| Interaction | TLX1 interactions | 2.34e-10 | 175 | 47 | 9 | int:TLX1 | |
| Interaction | NFIA interactions | 4.43e-10 | 188 | 47 | 9 | int:NFIA | |
| Interaction | PAX6 interactions | SOX5 KMT2C ARID1B KMT2D SATB1 ZFHX4 ATXN1 PAXIP1 HIPK2 FOXP1 ZFHX3 | 5.92e-10 | 366 | 47 | 11 | int:PAX6 |
| Interaction | KLF5 interactions | 6.13e-10 | 195 | 47 | 9 | int:KLF5 | |
| Interaction | PAX2 interactions | 1.01e-09 | 85 | 47 | 7 | int:PAX2 | |
| Interaction | IRF4 interactions | 1.01e-09 | 85 | 47 | 7 | int:IRF4 | |
| Interaction | SP7 interactions | SOX5 KMT2C ARID1B KMT2D SATB1 ZFHX4 ATXN1 PAXIP1 MAML1 FOXP1 | 1.66e-09 | 304 | 47 | 10 | int:SP7 |
| Interaction | FOXI1 interactions | 1.78e-09 | 92 | 47 | 7 | int:FOXI1 | |
| Interaction | FOXP4 interactions | 2.78e-09 | 98 | 47 | 7 | int:FOXP4 | |
| Interaction | LHX3 interactions | 1.00e-08 | 185 | 47 | 8 | int:LHX3 | |
| Interaction | GCM1 interactions | 1.13e-08 | 68 | 47 | 6 | int:GCM1 | |
| Interaction | FOXP2 interactions | 1.35e-08 | 70 | 47 | 6 | int:FOXP2 | |
| Interaction | FOXL1 interactions | 1.58e-08 | 196 | 47 | 8 | int:FOXL1 | |
| Interaction | SOX13 interactions | 1.71e-08 | 35 | 47 | 5 | int:SOX13 | |
| Interaction | ZFHX4 interactions | 1.75e-08 | 73 | 47 | 6 | int:ZFHX4 | |
| Interaction | TLX3 interactions | 2.03e-08 | 291 | 47 | 9 | int:TLX3 | |
| Interaction | SOX2 interactions | SOX6 SOX5 KMT2C PHC3 ARID1B KMT2D SATB1 ZFHX4 ATXN1 TP63 PAXIP1 MAML1 ANKRD17 HELZ FOXP1 ZFHX3 | 6.42e-08 | 1422 | 47 | 16 | int:SOX2 |
| Interaction | SOX9 interactions | 9.74e-08 | 97 | 47 | 6 | int:SOX9 | |
| Interaction | FOXP1 interactions | 1.25e-07 | 256 | 47 | 8 | int:FOXP1 | |
| Interaction | LHX1 interactions | 1.39e-07 | 103 | 47 | 6 | int:LHX1 | |
| Interaction | RCOR1 interactions | SOX6 SOX5 KMT2D HDAC5 SATB1 ZFHX4 ANKRD17 GIGYF2 ZFHX3 MRTFA | 1.64e-07 | 494 | 47 | 10 | int:RCOR1 |
| Interaction | TLE3 interactions | 1.81e-07 | 376 | 47 | 9 | int:TLE3 | |
| Interaction | TNRC6A interactions | 2.47e-07 | 280 | 47 | 8 | int:TNRC6A | |
| Interaction | SUMO1 interactions | 2.98e-07 | 287 | 47 | 8 | int:SUMO1 | |
| Interaction | PHIP interactions | 3.46e-07 | 197 | 47 | 7 | int:PHIP | |
| Interaction | VSX1 interactions | 4.45e-07 | 66 | 47 | 5 | int:VSX1 | |
| Interaction | NUP35 interactions | 4.98e-07 | 424 | 47 | 9 | int:NUP35 | |
| Interaction | NFIC interactions | 5.33e-07 | 210 | 47 | 7 | int:NFIC | |
| Interaction | ETV4 interactions | 5.57e-07 | 69 | 47 | 5 | int:ETV4 | |
| Interaction | POU5F1 interactions | SOX5 ARID1B PAXIP1 SASS6 ANKRD17 GIGYF2 HELZ ZFHX3 CHD1 HCFC1 | 7.62e-07 | 584 | 47 | 10 | int:POU5F1 |
| Interaction | SETD1B interactions | 8.47e-07 | 75 | 47 | 5 | int:SETD1B | |
| Interaction | TLX2 interactions | 9.32e-07 | 142 | 47 | 6 | int:TLX2 | |
| Interaction | HDAC1 interactions | SOX6 KMT2D HDAC5 SATB1 ZFHX4 ATXN1 ANKRD17 GIGYF2 ZFHX3 CHD1 HCFC1 TFCP2 MRTFA | 9.55e-07 | 1108 | 47 | 13 | int:HDAC1 |
| Interaction | PML interactions | MED15 SUPT20H SATB1 ATXN1 TP63 MAMLD1 AAK1 PAXIP1 HIPK2 HCFC1 TFCP2 RBCK1 | 1.05e-06 | 933 | 47 | 12 | int:PML |
| Interaction | NCOA6 interactions | 1.05e-06 | 145 | 47 | 6 | int:NCOA6 | |
| Interaction | ELF5 interactions | 1.14e-06 | 147 | 47 | 6 | int:ELF5 | |
| Interaction | KDM1A interactions | SOX6 PHC3 KMT2D HDAC5 SATB1 ZFHX4 ATXN1 ANKRD17 GIGYF2 FOXP1 ZFHX3 MRTFA | 1.15e-06 | 941 | 47 | 12 | int:KDM1A |
| Interaction | TOX3 interactions | 1.62e-06 | 37 | 47 | 4 | int:TOX3 | |
| Interaction | SATB2 interactions | 1.80e-06 | 159 | 47 | 6 | int:SATB2 | |
| Interaction | KLF4 interactions | 1.87e-06 | 160 | 47 | 6 | int:KLF4 | |
| Interaction | UBE2I interactions | 2.12e-06 | 654 | 47 | 10 | int:UBE2I | |
| Interaction | LHX4 interactions | 2.32e-06 | 166 | 47 | 6 | int:LHX4 | |
| Interaction | HCFC2 interactions | 2.34e-06 | 92 | 47 | 5 | int:HCFC2 | |
| Interaction | SMAD2 interactions | 2.71e-06 | 385 | 47 | 8 | int:SMAD2 | |
| Interaction | HNF4A interactions | 3.22e-06 | 275 | 47 | 7 | int:HNF4A | |
| Interaction | FHL2 interactions | 3.33e-06 | 396 | 47 | 8 | int:FHL2 | |
| Interaction | TOX interactions | 4.25e-06 | 14 | 47 | 3 | int:TOX | |
| Interaction | GATA3 interactions | 4.61e-06 | 187 | 47 | 6 | int:GATA3 | |
| Interaction | HCFC1 interactions | 4.89e-06 | 293 | 47 | 7 | int:HCFC1 | |
| Interaction | EN1 interactions | 5.65e-06 | 110 | 47 | 5 | int:EN1 | |
| Interaction | SATB1 interactions | 7.33e-06 | 116 | 47 | 5 | int:SATB1 | |
| Interaction | CNOT3 interactions | 8.26e-06 | 207 | 47 | 6 | int:CNOT3 | |
| Interaction | SMG7 interactions | 8.52e-06 | 319 | 47 | 7 | int:SMG7 | |
| Interaction | PAF1 interactions | 9.98e-06 | 214 | 47 | 6 | int:PAF1 | |
| Interaction | KMT2B interactions | 1.28e-05 | 130 | 47 | 5 | int:KMT2B | |
| Interaction | RAI2 interactions | 1.32e-05 | 20 | 47 | 3 | int:RAI2 | |
| Interaction | AR interactions | MED15 KMT2C ARID1B KMT2D ATXN1 PAXIP1 MAML1 HIPK2 FOXP1 ZFHX3 HCFC1 | 1.32e-05 | 992 | 47 | 11 | int:AR |
| Interaction | MYB interactions | 1.43e-05 | 133 | 47 | 5 | int:MYB | |
| Interaction | KLF3 interactions | 1.43e-05 | 228 | 47 | 6 | int:KLF3 | |
| Interaction | FOXC1 interactions | 1.43e-05 | 228 | 47 | 6 | int:FOXC1 | |
| Interaction | SOX15 interactions | 1.89e-05 | 141 | 47 | 5 | int:SOX15 | |
| Interaction | EYA4 interactions | 2.05e-05 | 243 | 47 | 6 | int:EYA4 | |
| Interaction | CIC interactions | 2.14e-05 | 673 | 47 | 9 | int:CIC | |
| Interaction | CTBP2 interactions | 2.22e-05 | 370 | 47 | 7 | int:CTBP2 | |
| Interaction | CPEB1 interactions | 2.24e-05 | 146 | 47 | 5 | int:CPEB1 | |
| Interaction | NCOR2 interactions | 3.27e-05 | 264 | 47 | 6 | int:NCOR2 | |
| Interaction | HNF1A interactions | 3.61e-05 | 80 | 47 | 4 | int:HNF1A | |
| Interaction | HNRNPLL interactions | 3.79e-05 | 163 | 47 | 5 | int:HNRNPLL | |
| Interaction | S100A2 interactions | 4.40e-05 | 412 | 47 | 7 | int:S100A2 | |
| Interaction | CEP85 interactions | 4.51e-05 | 169 | 47 | 5 | int:CEP85 | |
| Interaction | KMT2D interactions | 4.51e-05 | 169 | 47 | 5 | int:KMT2D | |
| Interaction | TNRC6B interactions | 4.72e-05 | 282 | 47 | 6 | int:TNRC6B | |
| Interaction | HMGA1 interactions | 4.90e-05 | 419 | 47 | 7 | int:HMGA1 | |
| Interaction | PRRC2C interactions | 5.51e-05 | 290 | 47 | 6 | int:PRRC2C | |
| Interaction | CNOT2 interactions | 5.77e-05 | 178 | 47 | 5 | int:CNOT2 | |
| Interaction | FOXP3 interactions | 5.94e-05 | 432 | 47 | 7 | int:FOXP3 | |
| Interaction | ZFP36 interactions | 6.25e-05 | 181 | 47 | 5 | int:ZFP36 | |
| Interaction | UBAP2L interactions | 6.41e-05 | 298 | 47 | 6 | int:UBAP2L | |
| Interaction | CREBBP interactions | 6.57e-05 | 599 | 47 | 8 | int:CREBBP | |
| Interaction | SOX17 interactions | 7.08e-05 | 95 | 47 | 4 | int:SOX17 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.88e-15 | 25 | 29 | 7 | 775 | |
| GeneFamily | SRY-boxes | 3.53e-06 | 19 | 29 | 3 | 757 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.57e-04 | 15 | 29 | 2 | 529 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.35e-03 | 34 | 29 | 2 | 487 | |
| GeneFamily | Forkhead boxes | 2.15e-03 | 43 | 29 | 2 | 508 | |
| GeneFamily | PHD finger proteins | 9.12e-03 | 90 | 29 | 2 | 88 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SUPT20H ATXN1 MAMLD1 ANKRD17 GIGYF2 HELZ ZFHX3 CHD1 SIK3 MN1 MRTFA | 3.96e-07 | 856 | 49 | 11 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 7.83e-07 | 171 | 49 | 6 | M39234 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.37e-06 | 300 | 49 | 7 | M8702 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 1.89e-06 | 199 | 49 | 6 | M9236 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 1.62e-05 | 807 | 49 | 9 | M16651 | |
| Coexpression | GSE17721_LPS_VS_CPG_0.5H_BMDC_UP | 3.40e-05 | 198 | 49 | 5 | M3982 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 3.57e-05 | 200 | 49 | 5 | M9391 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_329_3P_GENES | 3.85e-05 | 35 | 49 | 3 | MM17501 | |
| Coexpression | LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B | 4.16e-05 | 103 | 49 | 4 | M39240 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 4.31e-05 | 208 | 49 | 5 | M39233 | |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 4.95e-05 | 38 | 49 | 3 | M39244 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 8.44e-05 | 568 | 49 | 7 | MM3824 | |
| Coexpression | GAUTAM_EYE_CORNEA_MONOCYTES | 1.15e-04 | 256 | 49 | 5 | M43601 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 1.41e-04 | 141 | 49 | 4 | M39235 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22 | 1.86e-04 | 11 | 49 | 2 | M11594 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 2.03e-04 | 155 | 49 | 4 | M39246 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 2.45e-04 | 474 | 49 | 6 | M40991 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 2.82e-04 | 68 | 49 | 3 | M45669 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 3.29e-04 | 176 | 49 | 4 | M8952 | |
| Coexpression | GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN | 4.22e-04 | 188 | 49 | 4 | M7583 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP | 4.39e-04 | 190 | 49 | 4 | M9871 | |
| Coexpression | GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 4.57e-04 | 192 | 49 | 4 | M4689 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP | 4.84e-04 | 195 | 49 | 4 | M8006 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 4.84e-04 | 195 | 49 | 4 | M4195 | |
| Coexpression | GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP | 4.84e-04 | 195 | 49 | 4 | M3118 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP | 4.94e-04 | 196 | 49 | 4 | M4530 | |
| Coexpression | GSE27859_MACROPHAGE_VS_DC_DN | 4.94e-04 | 196 | 49 | 4 | M8588 | |
| Coexpression | GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN | 5.03e-04 | 197 | 49 | 4 | M6291 | |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 5.03e-04 | 197 | 49 | 4 | M5495 | |
| Coexpression | GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP | 5.13e-04 | 198 | 49 | 4 | M3249 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN | 5.13e-04 | 198 | 49 | 4 | M9234 | |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP | 5.13e-04 | 198 | 49 | 4 | M3104 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN | 5.23e-04 | 199 | 49 | 4 | M8415 | |
| Coexpression | GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 5.23e-04 | 199 | 49 | 4 | M9850 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 5.23e-04 | 199 | 49 | 4 | M9255 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 5.23e-04 | 199 | 49 | 4 | M4460 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 5.23e-04 | 199 | 49 | 4 | M3151 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 5.33e-04 | 200 | 49 | 4 | M9463 | |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 5.33e-04 | 200 | 49 | 4 | M7765 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_DN | 5.33e-04 | 200 | 49 | 4 | M3399 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 5.33e-04 | 200 | 49 | 4 | M6247 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | 5.33e-04 | 200 | 49 | 4 | M8954 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 5.33e-04 | 200 | 49 | 4 | M8620 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP | 5.33e-04 | 200 | 49 | 4 | M8836 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 5.80e-04 | 364 | 49 | 5 | M39057 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 6.47e-04 | 794 | 49 | 7 | MM982 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 4.75e-06 | 428 | 48 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.41e-06 | 328 | 48 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.35e-05 | 654 | 48 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 1.42e-05 | 836 | 48 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.53e-05 | 139 | 48 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 1.99e-05 | 249 | 48 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.00e-05 | 147 | 48 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 3.37e-05 | 407 | 48 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | 4.61e-05 | 175 | 48 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 4.71e-05 | 429 | 48 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.09e-05 | 90 | 48 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.43e-05 | 298 | 48 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 6.93e-05 | 806 | 48 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX6 SOX5 GTF2A1 SGTB FOXP2 TOX3 PAXIP1 HIPK2 SASS6 ZFHX3 CHD1 | 8.89e-05 | 1257 | 48 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.29e-05 | 478 | 48 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 9.78e-05 | 843 | 48 | 9 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 1.04e-04 | 850 | 48 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 1.09e-04 | 210 | 48 | 5 | GSM403995_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.11e-04 | 492 | 48 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 1.48e-04 | 224 | 48 | 5 | GSM403994_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.71e-04 | 231 | 48 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.93e-04 | 721 | 48 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.10e-04 | 730 | 48 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.16e-04 | 243 | 48 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 2.30e-04 | 388 | 48 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 2.33e-04 | 247 | 48 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 2.36e-04 | 390 | 48 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 3.09e-04 | 983 | 48 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX6 SOX5 GTF2A1 SGTB FOXP2 TOX3 PAXIP1 HIPK2 SASS6 ZFHX3 CHD1 | 3.29e-04 | 1459 | 48 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 3.56e-04 | 149 | 48 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 3.60e-04 | 791 | 48 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 4.08e-04 | 806 | 48 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 4.40e-04 | 815 | 48 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 5.37e-04 | 1060 | 48 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 5.54e-04 | 844 | 48 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | 6.04e-04 | 855 | 48 | 8 | gudmap_developingKidney_e13.5_podocyte cells_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.77e-04 | 312 | 48 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 6.97e-04 | 178 | 48 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 8.16e-04 | 493 | 48 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 8.29e-04 | 1370 | 48 | 10 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 8.42e-04 | 496 | 48 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 8.54e-04 | 188 | 48 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_200 | 9.26e-04 | 20 | 48 | 2 | gudmap_developingGonad_e11.5_testes_k2_200 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 9.44e-04 | 336 | 48 | 5 | GSM538413_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_100 | 9.73e-04 | 86 | 48 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.79e-04 | 195 | 48 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k1 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.MLN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 1.05e-03 | 344 | 48 | 5 | GSM538377_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_100 | 1.07e-03 | 89 | 48 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.07e-03 | 89 | 48 | 3 | gudmap_developingGonad_e11.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.09e-03 | 201 | 48 | 4 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.21e-03 | 532 | 48 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.29e-03 | 210 | 48 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.36e-03 | 747 | 48 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.36e-03 | 747 | 48 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | 1.36e-03 | 1208 | 48 | 9 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d100.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.36e-03 | 365 | 48 | 5 | GSM605904_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_100 | 1.45e-03 | 25 | 48 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | 1.51e-03 | 985 | 48 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 1.55e-03 | 989 | 48 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 1.61e-03 | 769 | 48 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.85e-03 | 232 | 48 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.97e-03 | 110 | 48 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 2.07e-03 | 804 | 48 | 7 | gudmap_developingGonad_e12.5_ovary_1000 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-11 | 193 | 49 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-09 | 192 | 49 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-09 | 199 | 49 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.19e-09 | 199 | 49 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-08 | 189 | 49 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.30e-08 | 190 | 49 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.70e-08 | 192 | 49 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.57e-08 | 196 | 49 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-08 | 198 | 49 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.54e-08 | 200 | 49 | 6 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.92e-07 | 156 | 49 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-06 | 183 | 49 | 5 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.79e-06 | 184 | 49 | 5 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-06 | 184 | 49 | 5 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-06 | 191 | 49 | 5 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-06 | 191 | 49 | 5 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-06 | 192 | 49 | 5 | ef8970e5389bd55c1624cd6dd01a7ca7abaa8950 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-06 | 193 | 49 | 5 | 95f5611dd9583f339b7c9f52bb478af204fb89ad | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 2.26e-06 | 193 | 49 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-06 | 194 | 49 | 5 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-06 | 195 | 49 | 5 | 497d4bfbc38bcafab37e8a9c20bc9141f2e78d2a | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.37e-06 | 195 | 49 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4|lymph-node_spleen / Manually curated celltypes from each tissue | 2.56e-06 | 198 | 49 | 5 | 2cbafcb03df3c9aca68371df500d18ab8dcc416c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-06 | 198 | 49 | 5 | ea6621a148a96c8ffa1a93a35c9e288545d2637a | |
| ToppCell | control-CD8+_T_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.62e-06 | 199 | 49 | 5 | 6a61ce7404c65e506091fee99a2001f5a9b39f31 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 2.69e-06 | 200 | 49 | 5 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.68e-05 | 157 | 49 | 4 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.88e-05 | 160 | 49 | 4 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.02e-05 | 162 | 49 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 3.73e-05 | 171 | 49 | 4 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-05 | 172 | 49 | 4 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.66e-05 | 181 | 49 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 182 | 49 | 4 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 182 | 49 | 4 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 182 | 49 | 4 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 182 | 49 | 4 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.86e-05 | 183 | 49 | 4 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.97e-05 | 184 | 49 | 4 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-05 | 184 | 49 | 4 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.07e-05 | 185 | 49 | 4 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.07e-05 | 185 | 49 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.07e-05 | 185 | 49 | 4 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.07e-05 | 185 | 49 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-05 | 186 | 49 | 4 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 186 | 49 | 4 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 5.18e-05 | 186 | 49 | 4 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.29e-05 | 187 | 49 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 187 | 49 | 4 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.40e-05 | 188 | 49 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-05 | 188 | 49 | 4 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 188 | 49 | 4 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.40e-05 | 188 | 49 | 4 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 189 | 49 | 4 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 189 | 49 | 4 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.51e-05 | 189 | 49 | 4 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 189 | 49 | 4 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 189 | 49 | 4 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.63e-05 | 190 | 49 | 4 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.63e-05 | 190 | 49 | 4 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.63e-05 | 190 | 49 | 4 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.74e-05 | 191 | 49 | 4 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.74e-05 | 191 | 49 | 4 | f398344aaa79fc93d792e241b634a6afe4aff33d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.74e-05 | 191 | 49 | 4 | 11da47d96f44ba629e3299667495e7daddbbe86c | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.74e-05 | 191 | 49 | 4 | 363fd576de11615bf5953f5e3f82f1b1c5083001 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.74e-05 | 191 | 49 | 4 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | COVID-19_Moderate-CD8+_T_naive|World / disease group, cell group and cell class | 5.74e-05 | 191 | 49 | 4 | c3385226915097f47d2f197166fc755227438524 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.74e-05 | 191 | 49 | 4 | ffcb2c8dbcf40281b439f4b719b5b341972ffb9a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.74e-05 | 191 | 49 | 4 | fda432a7f79664e8ffd5d03c1c69ec43bbac994b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.74e-05 | 191 | 49 | 4 | ffe88d1ad676c745c76db89f766062fd365329f4 | |
| ToppCell | remission-CD4+_T_naive|World / disease stage, cell group and cell class | 5.86e-05 | 192 | 49 | 4 | 4bd94ce876d70f93dbdfad1dcd09e1468213cf57 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 5.86e-05 | 192 | 49 | 4 | ad7207810116e73d461242e42071901b6a9f48c6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-05 | 192 | 49 | 4 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.86e-05 | 192 | 49 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | remission-CD4+_T_naive|remission / disease stage, cell group and cell class | 5.86e-05 | 192 | 49 | 4 | d96b2122e28c735d8002ad6eb2d3d52c8e9ccf2b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.98e-05 | 193 | 49 | 4 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.98e-05 | 193 | 49 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.98e-05 | 193 | 49 | 4 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.98e-05 | 193 | 49 | 4 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.98e-05 | 193 | 49 | 4 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.98e-05 | 193 | 49 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.98e-05 | 193 | 49 | 4 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Healthy/Control-CD4+_T_naive|Healthy/Control / Disease group and Cell class | 5.98e-05 | 193 | 49 | 4 | f5face746df3517c86d72e31ba8f1b78c4c6b481 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.98e-05 | 193 | 49 | 4 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.98e-05 | 193 | 49 | 4 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.98e-05 | 193 | 49 | 4 | 792315f409a57fa6a8a88c850060b1e089e062ea | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.98e-05 | 193 | 49 | 4 | 192432ce2f8f95f8b8fa3812d311d35ee2b89f86 | |
| ToppCell | Healthy_donor-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 6.10e-05 | 194 | 49 | 4 | bcaaa6b6ce5b3552f11311d8ee91c35b8ec065f8 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 6.10e-05 | 194 | 49 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.10e-05 | 194 | 49 | 4 | 2e2019a7bf57f257f0ff9b24eacff59dbb952ebb | |
| ToppCell | severe-CD4+_Tcm|severe / disease stage, cell group and cell class | 6.10e-05 | 194 | 49 | 4 | 380fbd19b72af6767f98bbf50329686b76d59c54 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 6.10e-05 | 194 | 49 | 4 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 6.10e-05 | 194 | 49 | 4 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 6.10e-05 | 194 | 49 | 4 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | Healthy_donor-CD4+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 6.10e-05 | 194 | 49 | 4 | a8a0368a4e0eb5654fdffc8a779b08ad402aa2eb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.10e-05 | 194 | 49 | 4 | a7bfc535546d3c1a4e0cbcfeb7da816b34303350 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.10e-05 | 194 | 49 | 4 | e0ccf18edbae09fc1068f1e923f1bc0d0ff44195 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.10e-05 | 194 | 49 | 4 | 31a98ce929ee6cf6a9747e384f9a06336af49fd5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.10e-05 | 194 | 49 | 4 | fc0504730ae576ff46ba0bc9f585c53ab78d914c | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 6.10e-05 | 194 | 49 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.10e-05 | 194 | 49 | 4 | d788d5bd1e651706e7e2d54ada546a5e84f86ff0 | |
| Drug | stanolone benzoate | 1.20e-05 | 3 | 46 | 2 | ctd:C040109 | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HT_HG-U133A | 4.40e-05 | 194 | 46 | 5 | 6756_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | 4.51e-05 | 195 | 46 | 5 | 5813_UP | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 46 | 5 | 6845_UP | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 6742_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 2392_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 2128_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 6043_DN | |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.82e-07 | 447 | 49 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 2.70e-06 | 2 | 49 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | reaction time measurement | 1.18e-05 | 658 | 49 | 8 | EFO_0008393 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 1.62e-05 | 4 | 49 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.76e-05 | 93 | 49 | 4 | C1535926 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.28e-05 | 346 | 49 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | heart disease (implicated_via_orthology) | 3.48e-05 | 38 | 49 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | hematocrit | 3.76e-05 | 1011 | 49 | 9 | EFO_0004348 | |
| Disease | grapefruit juice consumption measurement | 5.64e-05 | 7 | 49 | 2 | EFO_0010094 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.48e-05 | 139 | 49 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | sensory perception of sound | 9.65e-05 | 9 | 49 | 2 | GO_0007605 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.18e-04 | 57 | 49 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 1.47e-04 | 11 | 49 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.09e-04 | 69 | 49 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | breast carcinoma | 2.52e-04 | 1019 | 49 | 8 | EFO_0000305 | |
| Disease | brain measurement, neuroimaging measurement | 2.89e-04 | 550 | 49 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | schizophrenia (is_implicated_in) | 3.00e-04 | 78 | 49 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | atrial fibrillation | 3.70e-04 | 371 | 49 | 5 | EFO_0000275 | |
| Disease | hair colour measurement | 5.23e-04 | 615 | 49 | 6 | EFO_0007822 | |
| Disease | multisite chronic pain | 5.35e-04 | 95 | 49 | 3 | EFO_0010100 | |
| Disease | sunburn | 5.52e-04 | 96 | 49 | 3 | EFO_0003958 | |
| Disease | lifestyle measurement | 6.27e-04 | 235 | 49 | 4 | EFO_0010724 | |
| Disease | Major Depressive Disorder | 7.11e-04 | 243 | 49 | 4 | C1269683 | |
| Disease | childhood trauma measurement | 7.28e-04 | 24 | 49 | 2 | EFO_0007979 | |
| Disease | total blood protein measurement | 8.77e-04 | 449 | 49 | 5 | EFO_0004536 | |
| Disease | Unipolar Depression | 9.01e-04 | 259 | 49 | 4 | C0041696 | |
| Disease | Sezary Syndrome | 9.23e-04 | 27 | 49 | 2 | C0036920 | |
| Disease | wellbeing measurement | 9.66e-04 | 692 | 49 | 6 | EFO_0007869 | |
| Disease | cutaneous squamous cell carcinoma | 1.38e-03 | 33 | 49 | 2 | EFO_1001927 | |
| Disease | retinal vasculature measurement | 1.64e-03 | 517 | 49 | 5 | EFO_0010554 | |
| Disease | hoarding disorder | 1.64e-03 | 36 | 49 | 2 | EFO_0803361 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQHQQQLFLKQQQQQ | 461 | Q2M2I8 | |
| QQQQQQLATALHQQQ | 541 | Q2M2I8 | |
| QQYHQQNLSNNNLIP | 81 | Q9Y2F9 | |
| HHALQQQLNQFQQQQ | 186 | Q8NFD5 | |
| IQLQQQQQQSCQHLG | 896 | O75179 | |
| QQQQQQQQQQHLSRA | 216 | P54253 | |
| ILKKQQQQQQQQQHQ | 101 | O14646 | |
| QAQQQQQQHPVLHLQ | 406 | Q6ZW49 | |
| HQFSQQQLQFPQQQL | 461 | Q6ZW49 | |
| QQLQPFQQQHALQQQ | 486 | Q6ZW49 | |
| ALQQQFHQLQQHQLQ | 496 | Q6ZW49 | |
| FHQLQQHQLQQQQLA | 501 | Q6ZW49 | |
| QHQLQQQQLAQLQQQ | 506 | Q6ZW49 | |
| QQQLAQLQQQHSLLQ | 511 | Q6ZW49 | |
| QLQQQHSLLQQQQQQ | 516 | Q6ZW49 | |
| HSLLQQQQQQQIQQQ | 521 | Q6ZW49 | |
| QQQQLQEAQAQQQHH | 1696 | P51610 | |
| QQQKHLQQQQFLQRQ | 636 | Q92585 | |
| KQNQQDQHQIQVLEQ | 66 | Q9NP74 | |
| QQQQQQQFGSQHLLV | 1781 | Q8NEZ4 | |
| HFQQQQPLNLSQAQQ | 1031 | Q9H2X6 | |
| QQRKQQQQEGNYLQH | 251 | Q9BYM8 | |
| LQLEQIQQLQQQLHQ | 3291 | Q9Y6V0 | |
| IQQLQQQLHQQLEEQ | 3296 | Q9Y6V0 | |
| QQQQQQQQQLDLLFH | 76 | C9JC47 | |
| KQQEQLHLQLLQQQQ | 141 | O15409 | |
| QQQQLAAQQLVFQQQ | 206 | O15409 | |
| QQQVATQQLAFQQQL | 171 | Q9H334 | |
| FQQQLLQMQQLQQQH | 181 | Q9H334 | |
| QQQQQQQQLDLLFHQ | 81 | P0CG43 | |
| IKLHHQNQQQIQQQQ | 221 | Q96RN5 | |
| QHTLLNQQQNNLPEQ | 1376 | P42694 | |
| SHHQLILQQQQQQIQ | 321 | Q8NDX5 | |
| PSLLHYTQQQQQQQQ | 581 | Q8IZL2 | |
| QLAVQQQNFIQQQAL | 871 | Q96JP2 | |
| QQNFIQQQALILAQQ | 876 | Q96JP2 | |
| RQQQQQQHQHLLQKQ | 436 | Q9H3D4 | |
| HQQQQQQQQQQEKLP | 251 | Q8IZD4 | |
| QMQHLQYQQFLIQQQ | 621 | Q6Y7W6 | |
| LQQQQQQQQQQPDHS | 596 | Q13495 | |
| QALQQLVMQQQHQQF | 506 | Q9UQL6 | |
| ALQAQVQYQQQHEQQ | 221 | Q6UVJ0 | |
| QQQNDWQYHLQQHQQ | 306 | A0A1W2PPM1 | |
| APDHQSLQQQQQQQQ | 516 | Q10571 | |
| QQQIQQHQRQLAQAL | 1196 | Q9HCJ0 | |
| QQQSHQLVSLQQLQQ | 636 | Q3ZLR7 | |
| YQQEQHHQILQQQIQ | 681 | Q9Y2K2 | |
| QQQQQQQQEYQELFR | 1006 | Q9Y2K2 | |
| QLQILNQQQQQHHNY | 271 | Q969V6 | |
| NQQQQQHHNYQAILP | 276 | Q969V6 | |
| GLFNNHGLQVQQQQQ | 36 | Q9P2R7 | |
| HVPAEQIQQQQQQQQ | 586 | Q01826 | |
| QQQHKINLLQQQIQV | 246 | P35712 | |
| LLLQVQQQHQPQQQQ | 66 | P52655 | |
| EQIAKQQQQLIQQQH | 196 | Q9UN79 | |
| QQYQQNLQESLQKQQ | 3271 | Q86UP3 | |
| LREQQQQQQQQQQKH | 401 | Q12800 | |
| IFNTLQQQQQQLSQF | 631 | Q8NEM7 | |
| NHLYIKQQQQQQQQQ | 1456 | Q68DE3 | |
| HLQQQINQQQLQQQL | 496 | O15405 | |
| IQAGQQFAQQIQQQN | 266 | Q96EQ0 | |
| EQIARQQQQLLQQQH | 246 | P35711 | |
| QYQQSLQEAIQQQQQ | 3366 | Q15911 | |
| QPAQQQQQQQQQHSL | 3271 | O14686 | |
| QQQQQHLLGQVAIQQ | 3741 | O14686 | |
| RLVTAQQQQQQQQHQ | 3851 | O14686 |